Nephrology | Page 15 of 44 | Links Medicus Content Curation & Alerts in Medicine

RCT: Effect of tacrolimus vs. intravenous cyclophosphamide on complete or partial response in patients with lupus nephritis.

31 Mar, 2022 | 08:18h | UTC

Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter

In this RCT, oral tacrolimus was noninferior to intravenous cyclophosphamide for initial therapy of active lupus nephritis, with a more favorable safety profile. https://t.co/scz7lahVRU

— JAMA Network Open (@JAMANetworkOpen) March 30, 2022

Cluster RCT: A household salt substitution intervention is a cost-effective intervention for preventing stroke and improving quality of life.

29 Mar, 2022 | 10:16h | UTC

Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS) – Circulation

Commentary: ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving – HealthDay

Original Study: #ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

Former CDC director: Low sodium salt could save millions of lives – CNN

Is salt good for you after all? The evidence says no.

Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

New WHO benchmarks help countries reduce salt intake and save lives.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

Review: Acute kidney injury in critically ill patients with cancer.

29 Mar, 2022 | 09:47h | UTC

Acute Kidney Injury in Critically Ill Patients with Cancer – Clinical Journal of the American Society of Nephrology

Commentary on Twitter

Advances in cancer therapy have improved patient survival; however, AKI is common in patients with cancer. This Review highlights the epidemiology of AKI in critically ill patients with cancer, risk factors for AKI, & common pathologies linked to therapies https://t.co/AVUvGCqqwh pic.twitter.com/1GdM3P0h3j

— CJASN (@CJASN) March 28, 2022

Review: How to improve compliance to hypertension treatment.

28 Mar, 2022 | 08:31h | UTC

How to improve compliance to hypertension treatment – European Society of Cardiology

Commentary on Twitter

#NonAdherence is a major factor for suboptimal #BP control. A one-size-fits-all approach is not ideal. A personalised approach is needed to address it. @spoorthy_burli in #CVPracticeJournal https://t.co/mm1Tjd8fPT @HeartOTXHeartMD @iamritu @AnastasiaSMihai @KreutzReinhold pic.twitter.com/Gdd693gfmU

— European Society of Cardiology Journals (@ESC_Journals) March 25, 2022

Guideline: Evaluation and medical management of the kidney stone patient.

24 Mar, 2022 | 08:46h | UTC

Update – 2022 Canadian Urological Association guideline: Evaluation and medical management of the kidney stone patient – Canadian Urological Association Journal

Related Guidelines:

Canadian Urological Association guideline: Management of ureteral calculi – Abridged version – Canadian Urological Association Journal

Renal and ureteric stones: assessment and management – National Institute for Health and Care Excellence

Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement – Journal of Nephrology

The Urological Association of Asia clinical guideline for urinary stone disease – International Journal of Urology

M-A: The impact of cold ischemia time on outcomes of living donor kidney transplantation.

24 Mar, 2022 | 08:33h | UTC

The Impact of Cold Ischaemia Time on Outcomes of Living Donor Kidney Transplantation: A Systematic Review and Meta-Analysis – Journal of Clinical Medicine

Consensus Statement: Appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations.

23 Mar, 2022 | 10:11h | UTC

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM) – La radiologia medica

Another study shows intravenous radiocontrast use is not associated with reduced kidney function

ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated”

Editorial: Pig-to-human transplants take a leap toward reality.

22 Mar, 2022 | 08:31h | UTC

Pig-to-human transplants take a leap toward reality – Nature Medicine

Enabling patient choice: the “deciding not to decide” option for older adults facing dialysis decisions.

22 Mar, 2022 | 08:25h | UTC

Enabling Patient Choice: The “Deciding Not to Decide” Option for Older Adults Facing Dialysis Decisions – Journal of the American Society of Nephrology

Commentary: The “Deciding Not to Decide” Option Can Improve Older Adult Patient Care – Rutgers University-New Brunswick

Hypertension in the hospitalized patient: an update

18 Mar, 2022 | 08:18h | UTC

Hypertension in the hospitalized patient: An update – Nefrología

[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.

17 Mar, 2022 | 09:07h | UTC

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease – Lilly

Commentary on Twitter

Details of the design & pt characteristics now published:

6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9

— Martin Landray (@MartinLandray) March 16, 2022

Malignant Hypertension: Current perspectives and challenges.

17 Mar, 2022 | 09:03h | UTC

Malignant Hypertension: Current Perspectives and Challenges – Journal of the American Heart Association

Podcast: Cardiorenal Syndrome Pearls.

15 Mar, 2022 | 08:23h | UTC

#326 NephMadness 2022: Cardiorenal Syndrome – The Curbsiders

Systematic Review: Long-term outcomes among patients with advanced kidney disease who forgo maintenance dialysis.

15 Mar, 2022 | 08:11h | UTC

Long-term Outcomes Among Patients With Advanced Kidney Disease Who Forgo Maintenance Dialysis: A Systematic Review – JAMA Network Open

Commentaries:

Conservative Care for Kidney Failure—The Other Side of the Coin – JAMA Network Open

Study: Advanced kidney disease patients can survive, with quality life, without dialysis – UPI

Systematic Review: Antiplatelet agents for chronic kidney disease.

11 Mar, 2022 | 09:35h | UTC

Antiplatelet agents for chronic kidney disease – Cochrane Library

Bisphosphonate nephropathy: A case series and review of the literature.

9 Mar, 2022 | 08:32h | UTC

Bisphosphonate nephropathy: A case series and review of the literature – British Journal of Clinical Pharmacology

Ten myths about albumin.

7 Mar, 2022 | 00:44h | UTC

Ten myths about albumin – Intensive Care Medicine (free for a limited period)

Commentary on Twitter

Albumin, 10 myths
1️⃣leaks into interstitium
2️⃣ ⬇️volume expansion vs artificial colloids
3️⃣ ⬇️AKI
4️⃣ sepsis: ⬆️survival
5️⃣ ⬆️diuretics effects
6️⃣RRT: ⬆️ fluid removal
7️⃣cirrhosis: ⬇️mortality
8️⃣TBI: ⬆️mortality
9️⃣correcting hypoalb ⬇️mortality
🔟 ⬆️NaCl
📎 https://t.co/nGOHOLYRqY pic.twitter.com/YroygQNNUk

— Intensive Care Medicine (@yourICM) March 5, 2022

Hepatorenal Syndrome Type 1: From diagnosis ascertainment to goal-oriented pharmacologic therapy.

6 Mar, 2022 | 23:47h | UTC

Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy – Kidney360

Randomized Diagnostic Study: home blood pressure measurements correlate better with 24-h ambulatory monitoring measurements compared to clinic, and kiosk measurements.

4 Mar, 2022 | 09:41h | UTC

Clinic, Home, and Kiosk Blood Pressure Measurements for Diagnosing Hypertension: a Randomized Diagnostic Study – Journal of General Internal Medicine

Commentary: Home blood pressure monitoring may provide the basis for accurate diagnoses of hypertension – Kaiser Permanente

Systematic Review: Interventions for minimal change disease in adults with nephrotic syndrome.

4 Mar, 2022 | 08:47h | UTC

Interventions for minimal change disease in adults with nephrotic syndrome – Cochrane Library

Commentary: Interventions for minimal change disease in adults with nephrotic syndrome – Cochrane Library

M-A: Survival for waitlisted kidney failure patients receiving transplantation vs. remaining on waiting list.

2 Mar, 2022 | 08:46h | UTC

Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis – The BMJ

Guideline: Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis.

27 Feb, 2022 | 22:40h | UTC

Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline – The BMJ

Commentary on Twitter

New rapid recommendation makes a weak recommendation against plasma exchange in patients with low risk of end stage kidney disease, and a weak recommendation in favour of plasma exchange in patients with moderate-high risk of ESKD https://t.co/PeEjSuRIxI #BMJInfographic pic.twitter.com/YR55t6XYhS

— The BMJ (@bmj_latest) February 25, 2022